Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_assertion type Assertion NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_head.
- NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_assertion description "[Thus, TGF-alpha mRNA is overexpressed in approximately 10% of cervical cancers and in the majority of endometrial cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_provenance.
- NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_assertion evidence source_evidence_literature NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_provenance.
- NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_assertion SIO_000772 9259394 NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_provenance.
- NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_assertion wasDerivedFrom befree-20150227 NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_provenance.
- NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_assertion wasGeneratedBy ECO_0000203 NP731181.RApTNVp2zbfNbGS6O_7sFjFtVUvtNfDXXL6EwIUWJf85U130_provenance.